The cannabis-derived oral spray can now be prescribed for seizures associated with tuberous sclerosis complex (TCS), a rare genetic condition that causes benign tumors to develop in different parts of the body.
The Nevada Cannabis Compliance Board has begun investigating three state dispensaries for selling a product that twice failed microbial testing.
According to the new study from Lancet Psychiatry, a promising treatment for cannabis dependence could be right within reach of many cannabis consumers: CBD.
The scientists behind the new initiative at the National Institute of Standards and Technology also plan to help standardize the testing methods used for cannabis products, such as edibles, tinctures, and balms.
Sapphire Medical Clinics, one of the few medical cannabis clinics in the UK, has guaranteed the treatment of its first patient for one year.
If given approval, the new regulations could come into effect in a matter of weeks.
A US company is voluntarily recalling a swathe of hemp tincture products, intended for dog, cat, and human consumption, after the Florida Department of Health tested some samples and found dangerous levels of lead.
Which factors are tipping these THC concentrations over the legal limit? The soil? The sun? The strain? Right now, it’s not entirely clear. But one research group at West Virginia University want to change that.